We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Paper-Based DNA Amplification Test to Simplify Infectious Disease Diagnostics

By LabMedica International staff writers
Posted on 24 Jan 2016
Print article
Image: Targets on the paper test, left, change color to indicate infection (Photo courtesy of Matt Terry, McMaster University).
Image: Targets on the paper test, left, change color to indicate infection (Photo courtesy of Matt Terry, McMaster University).
A simple and rapid paper-based diagnostic platform for diseases caused by pathogenic microorganisms was described in a recent paper.

Investigators at McMaster University (Hamilton, Canada) have incorporated the reagents required for rolling circle DNA amplification (RCA) into a paper-pullulan matrix. Pullulan is an edible, mostly tasteless polysaccharide polymer consisting of maltotriose units. The chief commercial use of pullulan is in the manufacture of edible films that are used in various breath freshener or oral hygiene products.

Rolling circle replication is a process of unidirectional nucleic acid replication that can rapidly synthesize multiple copies of circular molecules of DNA or RNA, such as plasmids, the genomes of bacteriophages, and the circular RNA genome of some viruses.

The RCA technique, which can produce massive DNA amplicons that can be easily visualized, was found to be more efficient in the paper matrix than in solution, which the investigators attributed to a significantly higher localized concentration of immobilized DNA.

The investigators developed a fully functional paper device for sensitive DNA or microRNA detection via printing of all RCA-enabling molecules within a polymeric sugar film formed from pullulan, which was integrated with the paper device. This encapsulation not only stabilized the entrapped reagents at room temperature but also enabled colorimetric bioassays with minimal steps.

“The new test involves printing of all required components needed to amplify a DNA or RNA target directly on paper,” said contributing author Dr. John Brennan, professor of chemistry at McMaster University. “The user only needs to add the sample to the paper and wait a few minutes for a color to develop.”

The RCA paper test was described in the January 8, 2016, online edition of the journal Angewandte Chemie.

Related Links:

McMaster University


New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Automated Blood Typing System
IH-500 NEXT
New
Auto-Chemistry Analyzer
CS-1200
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.